Remed Co.,Ltd. (KOSDAQ:302550)
South Korea flag South Korea · Delayed Price · Currency is KRW
2,750.00
+35.00 (1.29%)
At close: Aug 24, 2026

Remed Financials Overview

Millions KRW. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
27,05224,50525,55418,53621,36320,195
Revenue Growth
10.52%-4.11%37.86%-13.23%5.79%21.41%
Gross Profit
15,09513,96314,0468,94711,07110,315
Operating Income
1,953725.841,121-2,8601,6611,123
Net Income
2,050526.27,172797.174,000752.33
Earnings Per Share
47.389.00223.0026.00130.5624.60
EPS Growth
-76.46%-95.96%757.69%-80.09%430.73%-

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
10,54813,02910,6796,25430,62936,418
Total Debt
5,9275,4337,77418,31119,55719,631
Net Cash (Debt)
4,6217,5962,905-12,05711,07116,787
Net Cash Growth
-49.35%161.49%---34.05%-23.83%
Net Cash Per Share
147.67246.4890.33-393.53361.36549.85

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
2,7122,3961,2453,4995,212-3,297
Capital Expenditures
-1,295-866.76-585.95-790.69-4,951-4,134
Free Cash Flow
1,4171,530658.572,708261.1-7,431
Free Cash Flow Growth
390.39%132.25%-75.68%937.24%--

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
55.80%56.98%54.97%48.27%51.82%51.08%
Operating Margin
7.22%2.96%4.39%-15.43%7.78%5.56%
Pretax Margin
5.07%-1.22%31.48%5.29%21.34%4.37%
Profit Margin
7.58%2.15%28.07%4.30%18.72%3.72%
FCF Margin
5.24%6.24%2.58%14.61%1.22%-36.80%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
57.30180.3215.38125.1018.92216.25
P/FCF Ratio
57.0062.04167.4836.82289.83-
PS Ratio
2.993.874.325.383.548.06